The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression

被引:161
作者
Minsky, N [1 ]
Oren, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
D O I
10.1016/j.molcel.2004.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histone modifications play a pivotal role in regulating transcription and other chromatin-associated processes. In yeast, histone H2B monoubiquitylation affects gene silencing. However, mammalian histone ubiquitylation remains poorly understood. We report that the Mdm2 oncoprotein, a RING domain E3 ubiquitin ligase known to ubiquitylate the p53 tumor suppressor protein, can interact directly with histones and promote in vitro monoubiquitylation of histones H2A and H2B. Moreover, Mdm2 induces H2B monoubiquitylation in vivo. Endogenous Mdm2 is tethered in vivo, presumably via p53, to chromatin comprising the p53-responsive p21(waf1) promoter, and Mdm2 overexpression enhances protein ubiquitylation in the vicinity of a p53 binding site within that promoter. Moreover, when recruited to a promoter in the absence of p53, Mdm2 can repress transcription dependently on its RING domain, suggesting that its E3 activity contributes to repression. Histone ubiquitylation may thus constitute a novel mechanism of transcriptional repression by Mdm2, possibly underlying some of its oncogenic activities.
引用
收藏
页码:631 / 639
页数:9
相关论文
共 51 条
[1]   The contribution of the acidic domain of MDM2 to p53 and MDM2 stability [J].
Argentini, M ;
Barboule, N ;
Wasylyk, B .
ONCOGENE, 2001, 20 (11) :1267-1275
[2]   Histone modifications in transcriptional regulation [J].
Berger, SL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (02) :142-148
[3]   Retinoblastoma protein recruits histone deacetylase to repress transcription [J].
Brehm, A ;
Miska, EA ;
McCance, DJ ;
Reid, JL ;
Bannister, AJ ;
Kouzarides, T .
NATURE, 1998, 391 (6667) :597-601
[4]   Gene silencing -: Trans-histone regulatory pathway in chromatin [J].
Briggs, SD ;
Xiao, TJ ;
Sun, ZW ;
Caldwell, JA ;
Shabanowitz, J ;
Hunt, DF ;
Allis, CD ;
Strahl, BD .
NATURE, 2002, 418 (6897) :498-498
[5]   REGULATION OF TRANSCRIPTION FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR BY THE MDM-2 ONCOGENE [J].
CHEN, JD ;
LIN, JY ;
LEVINE, AJ .
MOLECULAR MEDICINE, 1995, 1 (02) :142-152
[6]   Np95 is a histone-binding protein endowed with ubiquitin ligase activity [J].
Citterio, E ;
Papait, R ;
Nicassio, F ;
Vecchi, M ;
Gomiero, P ;
Mantovani, R ;
Di Fiore, PP ;
Bonapace, IM .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (06) :2526-2535
[7]   Deubiquitination of histone H2B by a yeast acetyltransferase complex regulates transcription [J].
Daniel, JA ;
Torok, MS ;
Sun, ZW ;
Schieltz, D ;
Allis, CD ;
Yates, JR ;
Grant, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) :1867-1871
[8]   MDM2: life without p53 [J].
Daujat, S ;
Neel, H ;
Piette, J .
TRENDS IN GENETICS, 2001, 17 (08) :459-464
[9]   Function and dysfunction of the human oncoprotein MDM2 [J].
Deb, SP .
FRONTIERS IN BIOSCIENCE, 2002, 7 :D235-D243
[10]  
DubsPoterszman MC, 1995, ONCOGENE, V11, P2445